Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma

H. Ortega, L. Katz, B. Hartley, S. Yancey (Research Triangle Park, United States Of America; Stockley Park, United Kingdom)

Source: Annual Congress 2013 –Asthma
Session: Asthma
Session type: Thematic Poster Session
Number: 855
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ortega, L. Katz, B. Hartley, S. Yancey (Research Triangle Park, United States Of America; Stockley Park, United Kingdom). Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Eur Respir J 2013; 42: Suppl. 57, 855

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Sputum neutrophil differential cell count in health and relationship to disease severity in asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014


Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Using induced sputum cell counts to guide management of difficult-to-treat asthmatics
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze?
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015


Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015

LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016



Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014


The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014